Galectin Therapeutics Inc (GALT)
3.03
-0.22
(-6.77%)
USD |
NASDAQ |
May 10, 16:00
3.025
0.00 (0.00%)
After-Hours: 20:00
Galectin Therapeutics Cash from Operations (Quarterly): -4.702M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.702M |
| September 30, 2023 | -7.637M |
| June 30, 2023 | -9.833M |
| March 31, 2023 | -10.79M |
| December 31, 2022 | -7.239M |
| September 30, 2022 | -8.347M |
| June 30, 2022 | -7.428M |
| March 31, 2022 | -8.042M |
| December 31, 2021 | -6.951M |
| September 30, 2021 | -4.998M |
| June 30, 2021 | -5.977M |
| March 31, 2021 | -6.382M |
| December 31, 2020 | -5.414M |
| September 30, 2020 | -8.212M |
| June 30, 2020 | -2.604M |
| March 31, 2020 | -4.371M |
| December 31, 2019 | -3.759M |
| September 30, 2019 | -1.475M |
| June 30, 2019 | -2.33M |
| March 31, 2019 | -3.284M |
| December 31, 2018 | -2.007M |
| September 30, 2018 | -1.577M |
| June 30, 2018 | -3.079M |
| March 31, 2018 | -3.516M |
| December 31, 2017 | -3.904M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.123M |
| June 30, 2017 | -5.002M |
| March 31, 2017 | -3.863M |
| December 31, 2016 | -4.865M |
| September 30, 2016 | -3.444M |
| June 30, 2016 | -4.61M |
| March 31, 2016 | -3.49M |
| December 31, 2015 | -4.601M |
| September 30, 2015 | -5.084M |
| June 30, 2015 | -2.987M |
| March 31, 2015 | -4.311M |
| December 31, 2014 | -3.113M |
| September 30, 2014 | -3.282M |
| June 30, 2014 | -2.412M |
| March 31, 2014 | -3.619M |
| December 31, 2013 | -1.646M |
| September 30, 2013 | -1.483M |
| June 30, 2013 | -1.932M |
| March 31, 2013 | -2.423M |
| December 31, 2012 | -1.751M |
| September 30, 2012 | -2.079M |
| June 30, 2012 | -2.184M |
| March 31, 2012 | -1.486M |
| December 31, 2011 | -1.542M |
| September 30, 2011 | -1.251M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.79M
Minimum
Mar 2023
-1.475M
Maximum
Sep 2019
-6.131M
Average
-6.382M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | -149.16M |
| Viking Therapeutics Inc | -6.134M |
| 89bio Inc | -39.72M |
| Terns Pharmaceuticals Inc | -19.32M |
| Enanta Pharmaceuticals Inc | -28.60M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 10.00M |
| Free Cash Flow | -32.96M |
| Free Cash Flow Per Share (Quarterly) | -0.076 |
| Free Cash Flow Yield | -18.08% |